Angiodynamics ANGO
NASDAQ ANGO
$15.11 -0.01 (-0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Angiodynamics (ANGO) Gains from Sales and Divestitures (2013 - 2024)

Updated

Angiodynamics (ANGO) posted Gains from Sales and Divestitures of $54.5 million for FY2024 (year ended May 31, 2024).

Analysis

Angiodynamics (ANGO) Gains from Sales and Divestitures (2013 - 2024) Analysis & Trends

  • Annual Gains from Sales and Divestitures shows a five-year compound annual growth rate of 3.2% (FY2019 to FY2024).
  • The FY2024 figure stands as the lowest annual Gains from Sales and Divestitures since FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Angiodynamics 630.09 Mn 458.02 Mn 46.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Feb 29, 2024 6.66 Mn
Aug 31, 2023 47.84 Mn
May 31, 2013 -90,000.00
API Access

Angiodynamics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ANGO&period=max&api_key=YOUR_API_KEY